Profil
Per Grufman is currently the Chief Executive Officer at BioCrucible Ltd. He previously worked as a Director at Karolinska Institutet, Vice President-Marine Research at Accuro Immunology AB, Vice President-Research & Development at AbSorber AB, and Vice President-Research & Development at LumiraDx Ltd. He holds a doctorate degree from Karolinska Institutet and a graduate degree from the University of Stockholm.
Postes actifs de Per Grufman
| Sociétés | Poste | Début |
|---|---|---|
BioCrucible Ltd.
BioCrucible Ltd. BiotechnologyHealth Technology Develops next-generation diagnostics based upon advances in bimolecular condensate formation | Directeur Général | 20/01/2023 |
Anciens postes connus de Per Grufman
| Sociétés | Poste | Fin |
|---|---|---|
| LUMIRADX | Corporate Officer/Principal | - |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Accuro Immunology AB
Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Develops and manufactures active immunotherapy products | Directeur Technique/Scientifique/R&D | 27/11/2009 |
AbSorber AB
AbSorber AB Medical SpecialtiesHealth Technology Develops products for allogeneic transplantation | Directeur Technique/Scientifique/R&D | 27/11/2009 |
Formation de Per Grufman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Immunology AB
Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Develops and manufactures active immunotherapy products | Health Technology |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbSorber AB
AbSorber AB Medical SpecialtiesHealth Technology Develops products for allogeneic transplantation | Health Technology |
BioCrucible Ltd.
BioCrucible Ltd. BiotechnologyHealth Technology Develops next-generation diagnostics based upon advances in bimolecular condensate formation | Health Technology |
LumiraDX Ltd.
LumiraDX Ltd. Medical SpecialtiesHealth Technology Develops point of care diagnostic testing systems | Health Technology |
















